My husband recently received a $50,000 inheritance. We have no idea what to do with it. We want to be wise, but everything is ...

Illimis Therapeutics has completed a Series B funding round, securing $42m to expedite the development of its Gas6-mediated ...

Alzheimer's disease, a progressive brain disorder, affects millions and is projected to increase. While age and genetics play ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.

As Alzheimer's disease progresses beyond the early stages, the behavior changes and emotional impacts of the disease can be ...

The number of Americans diagnosed with Alzheimer’s each year is expected to double by 2060, with the majority of cases affecting women.

The Alzheimer’s Drugs Market is anticipated to experience a compound annual growth rate (CAGR) of approximately 20% over the ...

As Alzheimer's disease progresses, behavioral and psychiatric issues become common, distressing, and even dangerous for ...

A new study found that semaglutides like Ozempic are linked to a lower risk of Alzheimer's disease and dementia. Below, a ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?